ATE190841T1 - Arzneimittel enthaltend argatroban analoga - Google Patents

Arzneimittel enthaltend argatroban analoga

Info

Publication number
ATE190841T1
ATE190841T1 AT94101051T AT94101051T ATE190841T1 AT E190841 T1 ATE190841 T1 AT E190841T1 AT 94101051 T AT94101051 T AT 94101051T AT 94101051 T AT94101051 T AT 94101051T AT E190841 T1 ATE190841 T1 AT E190841T1
Authority
AT
Austria
Prior art keywords
group
polycyclic compound
compound residue
benzene ring
condensed polycyclic
Prior art date
Application number
AT94101051T
Other languages
English (en)
Inventor
Matsuo Igaki
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE190841T1 publication Critical patent/ATE190841T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
AT94101051T 1993-01-25 1994-01-25 Arzneimittel enthaltend argatroban analoga ATE190841T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5010060A JPH06219948A (ja) 1993-01-25 1993-01-25 抗トロンビン剤及びその製造方法

Publications (1)

Publication Number Publication Date
ATE190841T1 true ATE190841T1 (de) 2000-04-15

Family

ID=11739847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94101051T ATE190841T1 (de) 1993-01-25 1994-01-25 Arzneimittel enthaltend argatroban analoga

Country Status (6)

Country Link
EP (1) EP0608828B1 (de)
JP (1) JPH06219948A (de)
AT (1) ATE190841T1 (de)
CA (1) CA2114153A1 (de)
DE (1) DE69423528T2 (de)
ES (1) ES2145067T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9426038D0 (en) 1994-12-22 1995-02-22 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
US6057314A (en) * 1995-12-21 2000-05-02 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
FR2795960B1 (fr) 1999-07-05 2001-10-19 Sanofi Elf Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
JP2007008857A (ja) * 2005-06-30 2007-01-18 Nisshin Pharma Inc 大豆油不けん化物含有組成物
KR20150108430A (ko) * 2005-09-01 2015-09-25 백스터 인터내셔널 인코포레이티드 가용화제로서의 산을 포함하는 아가트로반 제제
US7687516B2 (en) 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US7589106B2 (en) 2006-09-27 2009-09-15 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
CN102656213B (zh) * 2009-12-24 2015-06-17 东丽株式会社 具有抗血液凝固作用的亲水性高分子化合物
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
CN107773533A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种新型凝血酶抑制剂及其制备方法
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
JPH02129123A (ja) * 1988-11-07 1990-05-17 Mitsubishi Kasei Corp 抗血液凝固剤

Also Published As

Publication number Publication date
DE69423528T2 (de) 2000-09-14
ES2145067T3 (es) 2000-07-01
JPH06219948A (ja) 1994-08-09
DE69423528D1 (de) 2000-04-27
EP0608828A1 (de) 1994-08-03
CA2114153A1 (en) 1994-07-26
EP0608828B1 (de) 2000-03-22

Similar Documents

Publication Publication Date Title
ATE190841T1 (de) Arzneimittel enthaltend argatroban analoga
DE3881246T2 (de) Durch Benzhydryl N-substituierte heterocyclische Derivate, ihre Herstellung und ihre Verwendung.
ES2190428T3 (es) Antagonistas biciclicos de fibrinogeno.
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
YU172490A (sh) Novi 4-benzoil izoksazol derivati
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
EP0193148A3 (de) 2-(Alkoxy enthaltendes Acyl)Hydrazide von 8-Chlordibenz[B,F][1,4]Oxazepin-10(11H)-Carbonsäure
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
KR920018028A (ko) 콜레스테롤 생합성 억제제로서의 신규 아자데칼린 아미드 및 티오아미드
ATE190842T1 (de) Arzneizusammensetzungen enthaltend argatrobananaloge
HUT54350A (en) Insecticidal and nematocidal plant protective compositions, process for producing veterinary compositions suitable for killing helminths and protozoa, as well as process for producing 1-arylimidazoles used as active ingredient
KR910006309A (ko) 인지질 및 인지질 유도체를 유효 성분으로 하는 항비루스성 약제
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
PT90986A (pt) Processo para a preparacao de esteres de estramustina e de composicoes farmaceuticas que os contem
KR970707122A (ko) 퀴놀린 유도체(quinoline derivative)
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
KR900003177A (ko) 테트라시클릭계 우울증 치료제
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
KR890012973A (ko) 이미다졸 유도체
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
PT88462A (pt) Process for the preparation of macrolide compounds and of compositions containing them
HUT48253A (en) Herbicide compositions containing new macrolid compounds and process for producing new macrolid compounds and pharmaceutical compositions containing them as active components
KR890008151A (ko) 키놀린 카르복산의 유도체

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties